文献速递消化、代谢与肾脏急症儿科与产科急症

2022年4至6月16个国家人猴痘病毒感染病例分析

Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.
PubMed 文献 · N Engl J Med · 2022-07-21
一句话结论2022年4至6月16国528例猴痘病例中95%经性活动传播,95%出现皮疹、73%肛门生殖器病变,13%住院、无死亡。

该国际病例系列纳入2022年4月27日至6月24日16国43个中心经PCR确诊的528例猴痘病毒感染。98%为男同性恋或双性恋男性,41%合并HIV感染,中位年龄38岁;95%疑经性活动传播。95%出现皮疹(64%皮损≤10个),73%有肛门生殖器病变,41%有黏膜病变;皮疹前常见发热(62%)、乏力(41%)、肌痛(31%)、头痛(27%),淋巴结肿大56%。5%接受抗病毒治疗,13%(70例)住院,无死亡。作者认为需快速识别和诊断以遏制社区传播。

要点

  • 528例中95%疑经性活动传播,98%为男同性恋或双性恋男性,41%合并HIV感染,中位年龄38岁。
  • 95%出现皮疹,其中64%皮损≤10个;73%有肛门生殖器病变,41%有黏膜病变(54例为单个生殖器病变)。
  • 皮疹前常见发热62%、乏力41%、肌痛31%、头痛27%,淋巴结肿大56%。
  • 住院70例(13%),原因包括严重肛门直肠疼痛21例、软组织重叠感染18例、感染控制目的13例等;无死亡报告。
  • 377例接受性传播感染检测者中109例(29%)合并其他性传播感染。

适用人群与场景

  • 2022年4月27日至6月24日在16个国家43个中心经聚合酶链反应确诊的猴痘病毒感染病例,共528例。
  • 98%为男同性恋或双性恋男性,75%为白人,41%合并人类免疫缺陷病毒感染,中位年龄38岁。

处置流程与药物剂量

  • 5%的病例接受了抗病毒治疗。
  • 70例(13%)住院,住院原因包括疼痛管理(主要为严重肛门直肠疼痛,21例)、软组织重叠感染(18例)、咽炎限制经口摄入(5例)、眼部病变(2例)、急性肾损伤(2例)、心肌炎(2例)及感染控制目的(13例)。

红旗征与不能漏的情况

  • 严重肛门直肠疼痛需住院疼痛管理(21例)。
  • 软组织重叠感染(18例)、咽炎限制经口摄入(5例)、眼部病变(2例)、急性肾损伤(2例)、心肌炎(2例)为住院原因。

研究设计与关键结果

  • 国际病例系列,纳入2022年4月27日至6月24日16国43个中心经聚合酶链反应确诊的528例猴痘病毒感染。
  • 95%疑经性活动传播;95%出现皮疹,其中64%皮损≤10个;73%有肛门生殖器病变;41%有黏膜病变(54例为单个生殖器病变)。
  • 皮疹前常见发热(62%)、乏力(41%)、肌痛(31%)、头痛(27%);淋巴结肿大56%。
  • 377例接受性传播感染检测者中109例(29%)合并其他性传播感染。
  • 23例有明确暴露史者中位潜伏期为7天(范围3至20天)。
  • 32例精液分析中29例检出猴痘病毒DNA。
  • 5%接受抗病毒治疗,70例(13%)住院,无死亡报告。

证据类型、等级与局限

  • 证据类型:国际病例系列。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在猴痘传统流行区之外同时发现病例,凸显了快速识别和诊断病例以遏制进一步社区传播的需要。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Before April 2022, monkeypox virus infection in humans was seldom reported outside African regions where it is endemic. Currently, cases are occurring worldwide. Transmission, risk factors, clinical presentation, and outcomes of infection are poorly defined.

METHODS: We formed an international collaborative group of clinicians who contributed to an international case series to describe the presentation, clinical course, and outcomes of polymerase-chain-reaction-confirmed monkeypox virus infections.

RESULTS: We report 528 infections diagnosed between April 27 and June 24, 2022, at 43 sites in 16 countries. Overall, 98% of the persons with infection were gay or bisexual men, 75% were White, and 41% had human immunodeficiency virus infection; the median age was 38 years. Transmission was suspected to have occurred through sexual activity in 95% of the persons with infection. In this case series, 95% of the persons presented with a rash (with 64% having ≤10 lesions), 73% had anogenital lesions, and 41% had mucosal lesions (with 54 having a single genital lesion). Common systemic features preceding the rash included fever (62%), lethargy (41%), myalgia (31%), and headache (27%); lymphadenopathy was also common (reported in 56%). Concomitant sexually transmitted infections were reported in 109 of 377 persons (29%) who were tested. Among the 23 persons with a clear exposure history, the median incubation period was 7 days (range, 3 to 20). Monkeypox virus DNA was detected in 29 of the 32 persons in whom seminal fluid was analyzed. Antiviral treatment was given to 5% of the persons overall, and 70 (13%) were hospitalized; the reasons for hospitalization were pain management, mostly for severe anorectal pain (21 persons); soft-tissue superinfection (18); pharyngitis limiting oral intake (5); eye lesions (2); acute kidney injury (2); myocarditis (2); and infection-control purposes (13). No deaths were reported.

CONCLUSIONS: In this case series, monkeypox manifested with a variety of dermatologic and systemic clinical findings. The simultaneous identification of cases outside areas where monkeypox has traditionally been endemic highlights the need for rapid identification and diagnosis of cases to contain further community spread.

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. N Engl J Med. 2022. PMID: 35866746. doi:10.1056/NEJMoa2207323

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。